Opiate binding in calf thalamic membranes: a selective mu 1 binding assay

Area of Science:

• Neuropharmacology
• Receptor Binding Assays

Background:

• Opioid receptors, including mu and delta subtypes, are crucial in pain modulation and other physiological processes.
• Understanding the heterogeneity of opioid receptor binding is essential for developing targeted therapeutics.

Purpose of the Study:

• To characterize the binding sites for [3H][D-Ala2,D-Leu5]enkephalin ([3H]DADL) in bovine thalamic membranes.
• To differentiate between mu and delta opioid receptor populations and identify potential novel receptor subtypes.

Main Methods:

• Radioligand binding assays using [3H]DADL and other enkephalin analogs.
• Competition binding experiments with selective opioid receptor ligands like DPDPE, DAGO, and morphine.
• Analysis of binding characteristics, including affinity, sensitivity to inhibitors, and modulation by ions.

Main Results:

• Scatchard analysis revealed linear binding with a KD of 0.7 nM for [3H]DADL.
• Competition studies indicated two binding populations: 20% delta receptors (DPDPE-sensitive, morphine-insensitive) and 80% mu-like receptors.
• The predominant mu-like binding exhibited unique characteristics, including similar affinities for multiple ligands and distinct sensitivity to naloxonazine and magnesium, suggesting a novel mu 1 receptor subtype.
• [3H][D-Ser2,Leu5]enkephalin-Thr6 ([3H]DSLET) binding mirrored [3H]DADL results.

Conclusions:

• Bovine thalamus contains a mu receptor population (approximately 80% of [3H]DADL binding) distinct from classical morphine-selective mu receptors, identified as mu 1 receptors.
• Selective inhibition of delta receptors with DPDPE allows for homogeneous labeling of mu 1 sites.
• This selective assay facilitates further investigation into the function and pharmacology of mu 1 receptors.